HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of ibuprofen and methylprednisolone on chemotactic factor-induced transcutaneous hypoxia.

Abstract
We showed previously in vitro that ibuprofen, a nonsteroidal anti-inflammatory agent, at concentrations easily achievable in blood, inhibits polymorphonuclear leukocyte cell swelling and aggregation in response to chemotactic factor stimulation. To confirm this in vivo, we studied the ability of ibuprofen i.v. pretreatment to reverse the transcutaneous hypoxia induced by i.v. infusion of 1 nmol/kg of formyl-methionyl-leucyl-phenylalanine. This effect was compared with that of methylprednisolone. For ibuprofen and methylprednisolone, respectively, the maximum percentage of reversal of hypoxia was 85 and 106%; the dose required to produce 50% of maximum reversal was 2.7 and 4.6 mg/kg; and the serum drug concentration needed to achieve 50% of maximum reversal was 14 and 11 micrograms/ml. We conclude that ibuprofen could be a useful alternative to steroidal antiinflammatory agents for the prevention and treatment of complications of stimulated polymorphonuclear leukocytes.
AuthorsE G Maderazo, S P Breaux, C L Woronick
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 238 Issue 2 Pg. 453-6 (Aug 1986) ISSN: 0022-3565 [Print] United States
PMID3735126 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • N-Formylmethionine Leucyl-Phenylalanine
  • Oxygen
  • Ibuprofen
  • Methylprednisolone
Topics
  • Animals
  • Cell Aggregation (drug effects)
  • Dose-Response Relationship, Drug
  • Ibuprofen (pharmacology)
  • Methylprednisolone (pharmacology)
  • N-Formylmethionine Leucyl-Phenylalanine (antagonists & inhibitors, pharmacology)
  • Neutrophils (drug effects, metabolism)
  • Oxygen (metabolism)
  • Partial Pressure
  • Rabbits
  • Skin (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: